Who Paid My Doc Search
Menu
Organisation paid for research Program year 2025 Source: CMS Open Payments

WR Clinsearch LLC

Neither a doctor nor a teaching hospital

Research payments

$12,228,755

1,002 payments

Through program year 2025, WR Clinsearch LLC is reported as receiving $12,228,755 in research payments, across 1,002 payments.

By program year

7 rows
Year Kind Amount Payments
2025 Research $888,804 86
2024 Research $1,117,015 70
2023 Research $3,532,018 463
2022 Research $4,289,528 232
2021 Research $1,952,259 85
2020 Research $259,876 12
2019 Research $189,254 54

Breakdown

Who paid Research payments · program years 2019–2025
  1. Moderna TX, Inc. $7,142,074 662 payments
  2. Eli Lilly and Company $2,028,358 54 payments
  3. Bavarian Nordic A/S $1,461,869 32 payments
  4. Novavax Inc $1,105,613 96 payments
  5. Gilead Sciences, Inc. $124,710 44 payments
  6. Pfizer Inc. $105,246 35 payments
  7. Rhythm Pharmaceuticals, Inc. $87,461 24 payments
  8. GlaxoSmithKline, LLC. $79,836 24 payments
  9. Biohaven Pharmaceutical Holding Company Ltd. $60,146 21 payments
  10. Verona Pharma, Inc. $11,800 2 payments
Studies the money was for Research payments · program years 2019–2025
  1. A Phase 3, Randomized, Stratified, Observer-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1273 SARS-CoV-2 Vaccine in Adults Aged 18 Years and Older $6,926,493 313 payments
  2. ABNCoV2 Vaccine in Adult Subjects Previously Vaccinated for SARS-CoV-2 $1,449,869 30 payments
  3. A Study to Evaluate the Efficacy, Immune Response, and Safety of a COVID-19 Vaccine in Adults older than 18 Years With a Pediatric Expansion in Adolescents (12 to<18 Years) at Risk for SARS-CoV-2 $492,472 40 payments
  4. A Study of Ly3298176 (Tirzepatide) for the Maintenance of Body Weight Reduction in Participants Who Have Obesity Or Overweight With Weight-Related Comorbidities $459,304 3 payments
  5. A Phase 3, Randomized, Observer-Blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine (SARS-CoV-2 rS) With Matrix-M1 Adjuvant in Adult Participants older than or equal to 18 Years With a Pediatric Expansion in Adolescents (12 to < 18 Years) $302,595 14 payments
  6. Efficacy and Safety of Tirzepatide Once Weekly in Participants Without Type 2 Diabetes Who Have Obesity Or Are Overweight With Weight- Related Comorbidities: A Randomized, Double-Blind, Placebo-Controlled Trial (Surmount-1) $280,314 7 payments
  7. A Phase 3, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Retatrutide Compared to Tirzepatide in Adults Who Have Obesity $219,507 3 payments
  8. A Study of Orforglipron for the Maintenance of Body Weight Reduction in Participants Who Have Obesity Or Overweight With Weight-Related Comorbidities (Attain-Maintain) $217,359 3 payments
  9. A Phase 1/2, Randomized, Observer-Blind, Active-Controlled, Dose-Ranging Study to Evaluate the Safety, Reactogenicity and Immunogenicity of mRNA-1468, a Candidate Vaccine to Prevent Herpes Zoster (HZ) in Healthy Adults 50 Years of Age $191,153 341 payments
  10. A Phase 3B Randomized Controlled Study to Evaluate the Efficacy and Safety of Tirzepatide Compared to Semaglutide 2.4 MG in Adults Who Have Obesity Or Overweight With Weight-Related Comorbidities (Surmount-5) $175,064 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record